Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note released on Sunday morning. The firm issued a sell rating on the stock.

Separately, Craig Hallum raised shares of Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Price Performance

STRM stock traded down $0.04 during midday trading on Friday, hitting $2.69. The stock had a trading volume of 12,100 shares, compared to its average volume of 16,442. The business has a fifty day moving average price of $3.37 and a two-hundred day moving average price of $5.52. Streamline Health Solutions has a 1-year low of $1.85 and a 1-year high of $9.75. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61.

Streamline Health Solutions (NASDAQ:STRM) last released its earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The business had revenue of $4.48 million for the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.